BIOLASE (NASDAQ:BIOL) Coverage Initiated at StockNews.com

StockNews.com began coverage on shares of BIOLASE (NASDAQ:BIOL) in a research report released on Saturday morning. The brokerage issued a sell rating on the medical technology company’s stock.

BIOL has been the topic of several other reports. Ascendiant Capital Markets lowered their price objective on shares of BIOLASE from $3.50 to $2.00 and set a “buy” rating on the stock in a research report on Tuesday, September 3rd. Benchmark reiterated a “speculative buy” rating and set a $0.40 price objective on shares of BIOLASE in a research report on Wednesday, October 2nd.

BIOLASE Price Performance

NASDAQ:BIOL opened at $0.01 on Friday. The stock has a fifty day simple moving average of $0.05 and a 200 day simple moving average of $0.10. The firm has a market capitalization of $334,070.00, a price-to-earnings ratio of 0.00 and a beta of 0.67. BIOLASE has a 1-year low of $0.02 and a 1-year high of $1.94.

BIOLASE (NASDAQ:BIOL) last posted its quarterly earnings data on Thursday, August 8th. The medical technology company reported ($0.08) EPS for the quarter. The firm had revenue of $11.56 million for the quarter. BIOLASE had a negative net margin of 41.65% and a negative return on equity of 1,782.73%.

Hedge Funds Weigh In On BIOLASE

A hedge fund recently raised its stake in BIOLASE stock. Virtu Financial LLC grew its stake in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 143,537 shares of the medical technology company’s stock after acquiring an additional 131,248 shares during the period. Virtu Financial LLC owned 0.43% of BIOLASE worth $27,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 8.79% of the company’s stock.

About BIOLASE

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.